Deborra Mullins

1.5k total citations
31 papers, 1.1k citations indexed

About

Deborra Mullins is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Deborra Mullins has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 6 papers in Pharmacology. Recurrent topics in Deborra Mullins's work include Receptor Mechanisms and Signaling (17 papers), Neuropeptides and Animal Physiology (12 papers) and Stress Responses and Cortisol (4 papers). Deborra Mullins is often cited by papers focused on Receptor Mechanisms and Signaling (17 papers), Neuropeptides and Animal Physiology (12 papers) and Stress Responses and Cortisol (4 papers). Deborra Mullins collaborates with scholars based in United States, United Kingdom and Australia. Deborra Mullins's co-authors include M. Guzzi, Eric M. Parker, Robert A. Hodgson, Fuller W. Bazer, Ambikaipakan Balasubramaniam, R. Michael Roberts, Brian Salisbury, Joyce Hwa, Geoffrey B. Varty and Xiao–Ping Zhang and has published in prestigious journals such as Cell, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Deborra Mullins

31 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deborra Mullins United States	21	508	418	272	142	115	31	1.1k
Elisa Giannini Italy	18	541 1.1×	595 1.4×	185 0.7×	78 0.5×	111 1.0×	32	1.5k
Kiyomi Saeki Japan	26	909 1.8×	437 1.0×	220 0.8×	138 1.0×	26 0.2×	90	1.8k
Pierre Broqua France	14	291 0.6×	454 1.1×	277 1.0×	133 0.9×	133 1.2×	26	1.0k
Balázs Szőke United States	19	631 1.2×	421 1.0×	94 0.3×	36 0.3×	56 0.5×	48	1.4k
Yaacov Egozi Israel	13	426 0.8×	278 0.7×	183 0.7×	83 0.6×	53 0.5×	19	788
Juan M. Luque Spain	22	557 1.1×	727 1.7×	58 0.2×	50 0.4×	49 0.4×	41	1.6k
M. Silhol France	19	417 0.8×	405 1.0×	58 0.2×	54 0.4×	84 0.7×	28	1.2k
Jason C. Bermak United States	10	532 1.0×	400 1.0×	439 1.6×	62 0.4×	24 0.2×	11	1.1k
J.F. McKelvy United States	19	434 0.9×	584 1.4×	123 0.5×	147 1.0×	120 1.0×	30	1.1k
Vijay Chhajlani Sweden	22	725 1.4×	530 1.3×	977 3.6×	35 0.2×	39 0.3×	42	2.2k

Countries citing papers authored by Deborra Mullins

Since Specialization

Citations

This map shows the geographic impact of Deborra Mullins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborra Mullins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborra Mullins more than expected).

Fields of papers citing papers by Deborra Mullins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborra Mullins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborra Mullins. The network helps show where Deborra Mullins may publish in the future.

Co-authorship network of co-authors of Deborra Mullins

This figure shows the co-authorship network connecting the top 25 collaborators of Deborra Mullins. A scholar is included among the top collaborators of Deborra Mullins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborra Mullins. Deborra Mullins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deng, Qiaolin, Yeon‐Hee Lim, Rajan Anand, et al.. (2015). Use of molecular modeling aided design to dial out hERG liability in adenosine A2A receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 25(15). 2958–2962. 9 indexed citations

Aslanian, Robert, Tanweer A. Khan, Rongze Kuang, et al.. (2015). Discovery of aminoquinazoline derivatives as human A2A adenosine receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 26(4). 1348–1354. 7 indexed citations

Hodgson, Robert A., Deborra Mullins, Sherry Lu, et al.. (2014). Characterization of a novel vasopressin V1b receptor antagonist, V1B-30N, in animal models of anxiety-like and depression-like behavior. European Journal of Pharmacology. 730. 157–163. 25 indexed citations

Smith, Karen, Susan Browne, Srinivasan Jayaraman, et al.. (2014). Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice. European Journal of Pharmacology. 728. 31–38. 10 indexed citations

Jones, Nicole M., et al.. (2013). A2A receptor antagonists do not induce dyskinesias in drug-naive or l-dopa sensitized rats. Brain Research Bulletin. 98. 163–169. 20 indexed citations

Ho, Ginny D., W. Michael Seganish, Deen Tulshian, et al.. (2012). The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia. Bioorganic & Medicinal Chemistry Letters. 22(7). 2585–2589. 20 indexed citations

Ho, Ginny D., Shu‐Wei Yang, Terry L. Nechuta, et al.. (2011). The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia. Bioorganic & Medicinal Chemistry Letters. 22(2). 1019–1022. 28 indexed citations

Yang, Shu‐Wei, William T. McElroy, Zheng Tan, et al.. (2011). Discovery of orally active pyrazoloquinolines as potent PDE10 inhibitors for the management of schizophrenia. Bioorganic & Medicinal Chemistry Letters. 22(1). 235–239. 43 indexed citations

Scott, Jack D., Michael W. Miller, Sue‐Ing Lin, et al.. (2009). Tetrahydroquinoline sulfonamides as vasopressin 1b receptor anatgonists. Bioorganic & Medicinal Chemistry Letters. 19(21). 6018–6022. 14 indexed citations

10.

Mullins, Deborra, Nika Adham, David Hesk, et al.. (2008). Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y5 receptor and development of a novel Y5-selective radioligand. European Journal of Pharmacology. 601(1-3). 1–7. 10 indexed citations

11.

Mullins, Deborra, Cliona MacSweeney, Barbara Werner, et al.. (2008). Characterization of the V1a antagonist, JNJ-17308616, in rodent models of anxiety-like behavior. Psychopharmacology. 202(4). 711–718. 57 indexed citations

12.

Li, Guo‐Qing, Andrew W. Stamford, Ying Huang, et al.. (2007). Discovery of novel orally active ureido NPY Y5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(3). 1146–1150. 14 indexed citations

13.

Balasubramaniam, Ambikaipakan, Deborra Mullins, Shu Lin, et al.. (2006). Neuropeptide Y (NPY) Y₄Receptor Selective Agonists Based on NPY(32−36): Development of an Anorectic Y₄Receptor Selective Agonist with Picomolar Affinity. Journal of Medicinal Chemistry. 49(8). 2661–2665. 51 indexed citations

14.

Mullins, Deborra, Xiao–Ping Zhang, & Brian E. Hawes. (2002). Activation of extracellular signal regulated protein kinase by neuropeptide Y and pancreatic polypeptide in CHO cells expressing the NPY Y1, Y2, Y4 and Y5 receptor subtypes. Regulatory Peptides. 105(1). 65–73. 45 indexed citations

15.

Mullins, Deborra, M. Guzzi, Ling Xia, & Eric M. Parker. (2000). Pharmacological characterization of the cloned neuropeptide Y y6 receptor. European Journal of Pharmacology. 395(2). 87–93. 34 indexed citations

16.

Parker, Eric M., Ambikaipakan Balasubramaniam, M. Guzzi, et al.. (2000). [D-Trp34] neuropeptide Y is a potent and selective neuropeptide Y Y5 receptor agonist with dramatic effects on food intake☆. Peptides. 21(3). 393–399. 70 indexed citations

17.

Davis, Harry R., Deborra Mullins, Jesse M. Pines, et al.. (1998). Effect of Chronic Central Administration of Glucagon‐Like Peptide‐1 (7–36) Amide on Food Consumption and Body Weight in Normal and Obese Rats. Obesity Research. 6(2). 147–156. 49 indexed citations

18.

Parker, Eric M., Ambikaipakan Balasubramaniam, Robert E. Burrier, et al.. (1998). GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists. European Journal of Pharmacology. 349(1). 97–105. 98 indexed citations

19.

Gross, JL, D L Behrens, Deborra Mullins, Paul L. Kornblith, & Daniel L. Dexter. (1988). Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate.. PubMed. 48(2). 291–6. 81 indexed citations

20.

Presta, Marco, Paolo Mignatti, Deborra Mullins, & David Moscatelli. (1985). Human placental tissue stimulates bovine capillary endothelial cell growth, migration and protease production. Bioscience Reports. 5(9). 783–790. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact